Stereotaxis Inc
NYSE-MKT:STXS
Stereotaxis Inc
Gross Profit
Stereotaxis Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Stereotaxis Inc
NYSE-MKT:STXS
|
Gross Profit
$15m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-6%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Gross Profit
$8.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Gross Profit
$10.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Gross Profit
$13.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Gross Profit
$22.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Gross Profit
$4.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
See Also
What is Stereotaxis Inc's Gross Profit?
Gross Profit
15m
USD
Based on the financial report for Mar 31, 2024, Stereotaxis Inc's Gross Profit amounts to 15m USD.
What is Stereotaxis Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
-6%
Over the last year, the Gross Profit growth was -14%. The average annual Gross Profit growth rates for Stereotaxis Inc have been -10% over the past three years , -9% over the past five years , and -6% over the past ten years .